COLLABORATION, LICENSE AND OPTION AGREEMENTCollaboration, License and Option Agreement • February 24th, 2015 • Curis Inc • Biological products, (no disgnostic substances) • New York
THIS COLLABORATION, LICENSE AND OPTION AGREEMENT (the “Agreement”) is entered into as of January 18, 2015 (the “Effective Date”), by and between AURIGENE DISCOVERY TECHNOLOGIES LIMITED, a company organized under the laws of India, having an address of 39-40, KIADB Industrial Area, Phase II, Electronic City Hosur Road, Bangalore - 560100 Karnataka, India (“Aurigene”), and CURIS, INC., a corporation organized under the laws of Delaware, USA, having an address of 4 Maguire Road, Lexington, Massachusetts 02421-3112, USA (“Curis”).
COMMON STOCK PURCHASE AGREEMENTCommon Stock Purchase Agreement • February 24th, 2015 • Curis Inc • Biological products, (no disgnostic substances) • New York
THIS COMMON STOCK PURCHASE AGREEMENT (this “Agreement”), dated as of January 18, 2015, is between Curis, Inc., a Delaware corporation (the “Company”), and Aurigene Discovery Technologies Limited, a company organized under the laws of India (the “Purchaser”).
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • February 24th, 2015 • Curis Inc • Biological products, (no disgnostic substances) • Delaware
This REGISTRATION RIGHTS AGREEMENT (this “Agreement”), dated as of January 18, 2015, is entered into between Curis, Inc., a Delaware corporation (the “Company”), and Aurigene Discovery Technologies Limited, a company organized under the laws of India (the “Purchaser”).
TERMINATION AND TRANSITION AGREEMENTTermination and Transition Agreement • February 24th, 2015 • Curis Inc • Biological products, (no disgnostic substances)
THIS TERMINATION AND TRANSITION AGREEMENT (the “Transition Agreement”) is made as of February 5, 2015 (the “Termination Date”), by and between DEBIOPHARM INTERNATIONAL S.A., a Swiss corporation having its principal place of business at Forum «après-demain», Chemin Messidor 5-7, 1006 Lausanne, Switzerland (“Debiopharm”), and CURIS, INC., a corporation established under the laws of the State of Delaware, USA, having its principal place of business at 4 Maguire Road, Lexington, MA 02421-3112, United States of America (“Curis”).
